TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer’s disease
Author:
Publisher
Springer Vienna
Link
http://link.springer.com/content/pdf/10.1007/978-3-7091-6301-6_10.pdf
Reference32 articles.
1. Abu-Raya S, Blaugrund E, Trembovler V, Shilderman-Bloch E, Shohami E, et al (1999) Rasagiline, a monoamine oxidase-B inhibitor, protects NGF-differentiated PC12 cells against oxygen-glucose deprivation. J Neurosci Res 58: 456–463
2. Ansari KS, Yu PH, Kruck TPA, Tatton WG (1993) Rescue of axotomized immature rat motorneurons by R (-) deprenyl: Stereospecificity and independence from monoamine oxidase inhibition. J Neurosci 13: 4042–4053
3. Beatty WW, Butters N, Janowsky DS (1986) Patterns of memory failure after scopolamine treatment: Implications for cholinergic hypothesis of dementia. Behav Neural Biol 45: 196–211
4. Bejar C, Wang RH, Weinstock M (1999) Effect of of rivastigmine on scopolamine-induced memory impairment in rats. Eur J Pharmacol 383: 231–240
5. Chen Y, Shohami E, Constantini S, Weinstock M (1998) Rivastigmine, a brain-selective acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by closed-head injury in the mouse. J Neurotrauma 15: 231–237
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Superiority of the Triple-Acting 5-HT6R/5-HT3R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT6R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats;Journal of Medicinal Chemistry;2023-10-05
2. An Insight into the Asymmetric Resolution of 1‐Aminoindane Derivatives;ChemistrySelect;2023-05-04
3. Combination Therapy for the Treatment of Alzheimer’s Disease: Recent Progress and Future Prospects;Current Topics in Medicinal Chemistry;2022-09
4. Design, Synthesis, and Bioevaluation of Indole Core Containing 2-Arylidine Derivatives of Thiazolopyrimidine as Multitarget Inhibitors of Cholinesterases and Monoamine Oxidase A/B for the Treatment of Alzheimer Disease;ACS Omega;2022-03-10
5. Advances in prodrug design for Alzheimer’s disease: the state of the art;Expert Opinion on Drug Discovery;2022-02-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3